BRISTOL MYERS SQUIBB CO
Last 30 daysNo qualifying insider buying. Sales: $403.5K by 1 insider.
Showing the first 6 of 20 trades on this page.
EVP, General Counsel
Common Stock, $0.10 par value
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
EVP, General Counsel
Common Stock, $0.10 par value
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
EVP, General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
EVP,Chief Med Offr,Head of Dev
Common Stock, $0.10 par value
EVP, Corporate Affairs
Common Stock, $0.10 par value
EVP, Corporate Affairs
Common Stock, $0.10 par value
EVP, Corporate Affairs
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP and Controller
Common Stock, $0.10 par value
EVP,Chief Med Offr,Head of Dev
Common Stock, $0.10 par value
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
EVP,Chief Med Offr,Head of Dev
Common Stock, $0.10 par value
EVP,Chief Med Offr,Head of Dev
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, General Counsel
Common Stock, $0.10 par value
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
EVP, General Counsel
Common Stock, $0.10 par value
EVP, General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, General Counsel | Common Stock, $0.10 par valueOption exercise or conversion | 4,559$0 reported · see filing | Not established | Oct 2Filed Oct 5 · 3d later | SEC filing |
| EVP, General Counsel | Common Stock, $0.10 par valueExercise-price or tax withholding | 2,332$61.15 / share | $142.6K | Oct 2Filed Oct 5 · 3d later | SEC filing |
| EVP, General Counsel | Restricted Stock UnitsOption exercise or conversion | Derivative units4,559Exercise / conversion price not reported | Not a separate purchase | Oct 2Filed Oct 5 · 3d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units561$62.40 / derivative unit | $35K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units821$62.40 / derivative unit | $51.25K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units621$62.40 / derivative unit | $38.75K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units561$62.40 / derivative unit | $35K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units561$62.40 / derivative unit | $35K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| EVP,Chief Med Offr,Head of Dev | Common Stock, $0.10 par valueSale | 6,249$64.57 / share | $403.5K | Sep 9Filed Sep 10 · 1d later | SEC filing |
| EVP, Corporate Affairs | Common Stock, $0.10 par valueOption exercise or conversion | 1,236$66.92 / share | $82.71K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| EVP, Corporate Affairs | Common Stock, $0.10 par valueExercise-price or tax withholding | 633$66.92 / share | $42.36K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| EVP, Corporate Affairs | Restricted Stock UnitsOption exercise or conversion | Derivative units1,236Exercise / conversion price not reported | Not a separate purchase | Sep 1Filed Sep 3 · 2d later | SEC filing |
| SVP and Controller | Common Stock, $0.10 par valueSale | 500$67.50 / share | $33.75K | Aug 25Filed Aug 26 · 1d later | SEC filing |
| EVP,Chief Med Offr,Head of Dev | Common Stock, $0.10 par valueOption exercise or conversion | 51,172$0 reported · see filing | Not established | Aug 1Filed Aug 4 · 3d later | SEC filing |
| EVP,Chief Med Offr,Head of Dev | Common Stock, $0.10 par valueExercise-price or tax withholding | 26,175$65.31 / share | $1.71M | Aug 1Filed Aug 4 · 3d later | SEC filing |
| EVP,Chief Med Offr,Head of Dev | Restricted Stock UnitsOption exercise or conversion | Derivative units51,172Exercise / conversion price not reported | Not a separate purchase | Aug 1Filed Aug 4 · 3d later | SEC filing |
| EVP, General Counsel | Common Stock, $0.10 par valueOption exercise or conversion | 1,061$0 reported · see filing | Not established | Aug 1Filed Aug 4 · 3d later | SEC filing |
| EVP, General Counsel | Common Stock, $0.10 par valueExercise-price or tax withholding | 543$65.31 / share | $35.46K | Aug 1Filed Aug 4 · 3d later | SEC filing |
| EVP, General Counsel | Restricted Stock UnitsOption exercise or conversion | Derivative units1,061Exercise / conversion price not reported | Not a separate purchase | Aug 1Filed Aug 4 · 3d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units607$57.62 / derivative unit | $35K | Jun 30Filed Jul 2 · 2d later | SEC filing |
Showing the latest 20 of 43 trades. Show all 43 trades
Bristol-Myers Squibb Company · Stock
The filing reports a full sale for the member.
Thomas H TubervilleReporting Senate memberBristol-Myers Squibb Company Common Stock · Stock
The filing reports a purchase for the member.
Bristol-Myers Squibb Company Common Stock (BMY) · Stock
The filing reports a sale for a spouse.
Mike KellyReporting House memberBristol-Myers Squibb Company Common Stock (BMY) · Stock
The filing reports a sale for a joint account.
Julie JohnsonReporting House memberBristol-Myers Squibb Company Common Stock (BMY) · Stock
The filing reports a sale for the member.
Julia LetlowReporting House memberBristol-Myers Squibb Company Common Stock (BMY) · Stock
The filing reports a purchase for the member.
Julia LetlowReporting House memberBristol-Myers Squibb Company Common Stock (BMY) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBristol-Myers Squibb Company Common Stock (BMY) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBristol-Myers Squibb Company Common Stock (BMY) · Stock
The filing reports a partial sale for a joint account.
Julie JohnsonReporting House memberBristol-Myers Squibb Company Common Stock (BMY) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House member